← Back to Search

Assistive Technology

AAC-LaRc for Hemoglobinopathy (NAIL Trial)

N/A
Waitlist Available
Led By Aimee Dietz, PhD
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3years
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand how to use technology to restore language in people who have suffered a stroke, and identify which areas of the brain are responsible for these changes.

Eligible Conditions
  • Hemoglobinopathy
  • Aphasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Connectivity Indices
Visual Regions of Interest Activation intensity
Western Aphasia Battery-Revised Aphasia Quotient
Secondary study objectives
Communication Effectiveness Index (CETI)
Communication analyses
Discourse Analyses
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AAC-LaRcExperimental Treatment1 Intervention
all participants receive the experimental treatment

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
435 Previous Clinical Trials
635,318 Total Patients Enrolled
Children's Hospital Medical Center, CincinnatiOTHER
834 Previous Clinical Trials
6,564,969 Total Patients Enrolled
Aimee Dietz, PhD2.77 ReviewsPrincipal Investigator - University of Cincinnati
University of Cincinnati
5Patient Review
Dr. Dietz has been my physician for nearly three decades now. He's always been a great listener, and provides referrals to specialists when needed. I appreciate his osteopathic approach to care, which takes a more holistic perspective. He's also been involved in training and mentoring future physicians, which I think is fantastic.
~3 spots leftby Nov 2025